Literature DB >> 12766934

Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers.

Sheila J Asghar1, Veronique A M I Tanay, Glen B Baker, Andy Greenshaw, Peter H Silverstone.   

Abstract

Acute administration of the stimulant dextro-amphetamine produces multiple physiological, subjective cognitive and biochemical changes. These effects are similar to those seen in mania, and may be a useful model for mania. The aim of the present study was more fully to determine the multiple effects of dextro-amphetamine and to relate these to changes in plasma levels of the drug. In a double-blind, placebo-controlled crossover study in 25 healthy volunteers (ages 18-45), the effects of 25 mg of oral dextro-amphetamine were examined. Physiological, subjective, cognitive changes, concentrations of amino acids and metabolites of biogenic amines period were related to changes in plasma amphetamine concentrations over 500 min. Peak concentrations of dextro-amphetamine occurred at 2.5-3.5 h post-administration and levels decreased to 75% of peak value after 500 min. The results from the present study indicate that the subjective psychological, cognitive and blood pressure changes frequently did not mirror the time course of plasma levels of the drug. Thus, there was no clear-cut relationship between plasma levels and effects. In addition, dextro-amphetamine caused no significant changes in amino acids or amino metabolite concentrations. In conclusion, while dextro-amphetamine administration definitely causes several changes which are seen in mania, there remain some physiological and metabolic differences between these two conditions. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766934     DOI: 10.1002/hup.480

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  20 in total

1.  Effects of d-amphetamine on simulated driving performance before and after sleep deprivation.

Authors:  Magnus Hjälmdahl; Anna Vadeby; Asa Forsman; Carina Fors; Gunnel Ceder; Per Woxler; Robert Kronstrand
Journal:  Psychopharmacology (Berl)       Date:  2012-05-26       Impact factor: 4.530

2.  Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects.

Authors:  Joshua A Lile; Shanna Babalonis; Cleeve Emurian; Catherine A Martin; Daniel P Wermeling; Thomas H Kelly
Journal:  J Clin Pharmacol       Date:  2010-07-29       Impact factor: 3.126

Review 3.  Investigating the mechanism(s) underlying switching between states in bipolar disorder.

Authors:  Jared W Young; Davide Dulcis
Journal:  Eur J Pharmacol       Date:  2015-03-23       Impact factor: 4.432

4.  The effects of progesterone pretreatment on the response to oral d-amphetamine in Women.

Authors:  Stephanie C Reed; Frances R Levin; Suzette M Evans
Journal:  Horm Behav       Date:  2010-04-24       Impact factor: 3.587

5.  The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance.

Authors:  Beata Y Silber; Rodney J Croft; Katherine Papafotiou; Con Stough
Journal:  Psychopharmacology (Berl)       Date:  2006-06-08       Impact factor: 4.530

Review 6.  The neurobiology of the switch process in bipolar disorder: a review.

Authors:  Giacomo Salvadore; Jorge A Quiroz; Rodrigo Machado-Vieira; Ioline D Henter; Husseini K Manji; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2010-05-04       Impact factor: 4.384

7.  The effects of dexamphetamine on the resting-state electroencephalogram and functional connectivity.

Authors:  Matthew A Albrecht; Gareth Roberts; Greg Price; Joseph Lee; Rajan Iyyalol; Mathew T Martin-Iverson
Journal:  Hum Brain Mapp       Date:  2015-11-18       Impact factor: 5.038

8.  GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.

Authors:  Jared W Young; Andrew K L Goey; Arpi Minassian; William Perry; Martin P Paulus; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2009-12-18       Impact factor: 4.530

Review 9.  Trace amine-associated receptors as emerging therapeutic targets.

Authors:  Tatyana D Sotnikova; Marc G Caron; Raul R Gainetdinov
Journal:  Mol Pharmacol       Date:  2009-04-23       Impact factor: 4.436

10.  Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology.

Authors:  Christopher T Smith; Jessica Weafer; Ronald L Cowan; Robert M Kessler; Abraham A Palmer; Harriet de Wit; David H Zald
Journal:  J Psychopharmacol       Date:  2016-02-15       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.